EMMA Endometrial Microbiome Metagenomic Analysis

The most comprehensive and precise panel, encompassing the most frequently detected and clinically relevant bacteria to evaluate the endometrium at the microbiological level

EMMA & ALICE just got smarter!

Powered by the most scientific and clinical support, EMMA&ALICE is the most widely used endometrial microbiome test worldwide and the only commercially available test that delivers an endometrial-specific bacterial panel.

Leveraging our experience, we continue to deliver advancements to the analysis and optimization of the endometrial microbiome.

We are excited to introduce our newest update that includes:

• A fully enhanced view of the Lactobacillus population, allowing for a better understanding of the endometrium’s ability to defend against the colonization of pathogenic bacteria.

• Simplified and easier to interpret Lactobacillus results enabling faster decision making for a patient’s personalized treatment plan.

• The most up-to-date reporting methodology, backed by prospective trials, to deliver the most optimal patient outcomes (Moreno et al., 2022).

Overview

Upgraded EMMA
Benefits
Indications

What is the EMMA test – Endometrial Microbiome Metagenomic Analysis?

EMMA is a test that analyses the endometrial microbiome to help identify abnormalities associated with a poor reproductive prognosis.
EMMA assesses the endometrial microbiome, providing information about the most common and relevant bacteria, including those linked to higher pregnancy rates. EMMA also includes ALICE, which detects potentially pathogenic bacteria that can cause chronic endometritis.
Igenomix has analysed over 70,000 clinical samples during the last 5 years.
Through our experience with the EMMA&ALICE tests, we have identified the bacterial pathogens most frequently detected in the endometrium.
Based on this data, we have developed the most comprehensive and precise panel, encompassing all clinically relevant bacteria, with most identified at the species level, enabling more precise and targeted treatments.

What is the procedure?

Why use EMMA test?

EMMA uses RT-PCR technology to provide endometrial microbiome information by analysing the presence and quantity of the most common and relevant bacterial pathogens of the reproductive tract.
EMMA also includes ALICE, which detects potentially pathogenic bacteria that can cause chronic endometritis.
EMMA determines whether the endometrial microbial environment is optimal or not for embryo implantation.

Who should use the EMMA?

Patients with repeated implantation failure (RIF)
Patients with recurrent pregnancy loss (RPL)

*Moreno et al., 2016

Test limitations

These tests are not able to detect resistance to antibiotics
A negative result doesn’t rule out the presence of other endometrial pathogens

Documentation

EMMA Specialists' documents

Authors: Moreno I, Garcia-Grau I, Perez-Villaroya D, Gonzalez-Monfort M, Bahçeci M, Barrionuevo M. J, Taguchi S, Puente E, Dimattina M, Lim M. W, Meneghini G, Aubuchon M, Leondires M, Izquierdo A, Perez-Olgiati M., Chavez A., Seethram K., Bau D., Gomez C., Valbuena D, Vilella F, Simon C

Publication: Microbiome. 2022 Jan 4;10(1):1. doi: 10.1186/s40168-021-01184-w.

PMID: 34980280

Title: Evidence that the endometrial microbiota has an effect on implantation success or failure

Authors: Moreno I, Codoñer F, Vilella F, Valbuena D, Martinez-Blanch J F, Jimenez-Almazán J, Alonso R, Alamá P, Remohí J, Pellicer A, Ramon D, Simon C

Publication: Am J Obstet Gynecol. 2016 Dec;215(6):684-703. doi: 10.1016/j.ajog.2016.09.075. Epub 2016 Oct 4.

PMID: 27717732

Title: Human Microbiome Project Consortium – Structure, function and diversity of the healthy human microbiome

Authors: Human Microbiome Project Consortium

Publication: Nature. 2012 Jun 13;486(7402):207-14. doi: 10.1038/nature11234.

PMID: 22699609

If you're a little lost with this technical information...

Can we help you?

I’m not a health specialist

Igenomix and fertility

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility specialists worldwide, we investigate human reproduction to change the lives of those who are trying to conceive.